{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:49:57Z","timestamp":1746060597213},"reference-count":19,"publisher":"Pharmaceutical Society of Japan","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2013]]},"DOI":"10.1248\/bpb.b12-01006","type":"journal-article","created":{"date-parts":[[2013,11,30]],"date-time":"2013-11-30T22:56:31Z","timestamp":1385852191000},"page":"1891-1901","source":"Crossref","is-referenced-by-count":3,"title":["Quantitative Evaluation of Initial Symptoms as Predictors to Detect Adverse Drug Reactions Using Bayes\u2019 Theory: Expansion and Evaluation of Drug-Adverse Drug Reaction\u2013Initial Symptom Combinations Using Adverse Event Reporting System Database"],"prefix":"10.1248","volume":"36","author":[{"given":"Daisuke","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Department of Analytical Pharmaceutics and Informatics, Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Hosaka","sequence":"additional","affiliation":[{"name":"Asahi-Chozai Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiko","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Analytical Pharmaceutics and Informatics, Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimie","family":"Ohshima","sequence":"additional","affiliation":[{"name":"Asahi-Chozai Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Kutsuma","sequence":"additional","affiliation":[{"name":"Asahi-Chozai Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Oshima","sequence":"additional","affiliation":[{"name":"Department of Analytical Pharmaceutics and Informatics, Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Okuno","sequence":"additional","affiliation":[{"name":"Department of Systems Biosciences for Drug Discovery, Graduate School of Pharmaceutical Sciences, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Ohshima S, Ieda M, Yamamoto M, Kobayashi D. Quantitative evaluation method of information value of initial symptoms based on Bayesian theory. <i>Yakugaku Zasshi<\/i>, 132, 763\u2013768 (2012).","DOI":"10.1248\/yakushi.132.763"},{"key":"2","unstructured":"2) Scandellari C. The Bayesian approach to evaluation of diagnostic data. <i>Ann. Ist. Super. Sanita<\/i>, 27, 385\u2013393 (1991)."},{"key":"3","unstructured":"3) Ministry of Health, Labour and Welfare. \u201cthe Manual for Handling Disorders due to Adverse Drug Reactions.\u201d: \u2039http:\/\/www.mhlw.go.jp\/topics\/2006\/11\/tp1122-1.html\u203a, cited 6 May, 2013."},{"key":"4","unstructured":"4) Saito M. Introduction of \u201cthe manual for handling disorders due to adverse drug reactions\u201d: focus on the antibiotics related severe adverse drug reactions. <i>Jpn. J. Antibiot.<\/i>, 61, 269\u2013288 (2008)."},{"key":"5","unstructured":"5) Jose J, Rao PG. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. <i>Pharmacol. Res.<\/i>, 54, 226\u2013233 (2006)."},{"key":"6","unstructured":"6) Colloca L, Finniss D. Noceboeffects, patient-clinician communication, and therapeutic outcomes. <i>JAMA<\/i>, 307, 567\u2013568 (2012)."},{"key":"7","unstructured":"7) U.S. Food and Drug Administration. \u201cAERS Reporting by Healthcare Providers and Consumers by Year (As of December 31, 2010).\u201d: \u2039http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/ucm070456.htm\u203a, cited 10 May, 2013."},{"key":"8","unstructured":"8) Wu J, Song Y, Li H, Chen J. Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report. <i>Eur. J. Clin. Pharmacol.<\/i>, 65, 1169\u20131174 (2009)."},{"key":"9","unstructured":"9) Interview form of cibenzoline succinate tablets, cited 11 May, 2013."},{"key":"10","unstructured":"10) Ministry of Health, Labour and Welfare. \u201cInstructions for Description on Drug Usages\u201d (the 607th Notification from the Pharmaceutical Affairs Bureau issued on April 25th, 2007)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ohashi Y. Progress report of the working group on \u201cfuture postmarketing surveillance (PMS) in Japan.\u201d <i>Jpn. J. Pharmacoepidemiol.<\/i>, 8, 1\u201335 (2003).","DOI":"10.3820\/jjpe1996.8.1"},{"key":"12","unstructured":"12) Watanabe S, Nakano Y, Nomura K. Steps in developing a database of drug use-result surveillance: as an example of anti-hyperlipidemia drugs. <i>Jpn. J. Pharmacoepidemiol.<\/i>, 17, 87\u201397 (2012)."},{"key":"13","unstructured":"13) Gn\u00e4dinger M, Mellinghoff HU. The out-of-focus bias in drug surveillance. <i>Eur. J. Clin. Pharmacol.<\/i>, 69, 357\u2013359 (2013)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Fujita T. Signal detection of adverse drug reactions. <i>Jpn. J. Pharmacoepidemiol.<\/i>, 14, 27\u201336 (2009).","DOI":"10.3820\/jjpe.14.27"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Fletcher AP. Spontaneous adverse drug reaction reporting <i>vs.<\/i> event monitoring: a comparison. <i>J. R. Soc. Med.<\/i>, 84, 341\u2013344 (1991).","DOI":"10.1177\/014107689108400612"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Raschi E, Piccinni C, Poluzzi E, Marchesini G, Ponti F D, The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database, Acta Diabetol: Published on line 19 October 2011.","DOI":"10.1007\/s00592-011-0340-7"},{"key":"17","unstructured":"17) Developing reliable internet-based surveys, SSJDA-42.: \u2039https:\/\/ssjda.iss.u-tokyo.ac.jp\/rps\/RPS042.pdf\u203a, cited 11 May, 2013."},{"key":"18","unstructured":"18) Ghajar BM, Lanct\u00f4t KL, Shear NH, Naranjo CA. Bayesian differential diagnosis of a cutaneous reaction associated with the administration of sulfonamides. <i>Semin. Dermatol.<\/i>, 8, 213\u2013218 (1989)."},{"key":"19","unstructured":"19) Endo T, Watanabe N, Goto K, Kutsuma N, Komada F, Saitoh Y, Kobayashi D, Morimoto Y. Overlapping of the clinically significant adverse reaction of drugs in the polypharmacy. <i>Jpn. J. Pharm. Health Care Sci.<\/i>, 28, 157\u2013163 (2002)."}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/36\/12\/36_b12-01006\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T04:58:08Z","timestamp":1615870688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/36\/12\/36_b12-01006\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b12-01006","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}